Tradestie Institutional Equity Comparison Engine
UFPT vs AORT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
UFPT Overall Edge
UFPT Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to UFP Technologies Inc (UFPT) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, UFPT trades at 24.7x Forward P/E with 15.4% operating margin (+11.6% YoY revenue) versus AORT at 35.5x Forward P/E and 7.6% operating margin (+9.2% YoY). In options structure, UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro) against AORT sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
UFPT
UFPT 24.7x vs AORT 35.5x Fwd P/E
Growth & Margin Winner
UFPT
Op Margin 15.4% vs 7.6% ยท YoY +11.6% vs +9.2%
Momentum & Technical Winner
UFPT
1Y +27.4% vs -59.5% ยท 52W Pos 74% vs 1%
Options & Structure Winner
UFPT
UNCLASSIFIED (3rd %ile IV) vs BREAKDOWN (20th %ile IV)
UFPT
NASDAQ
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap
$2.4B
1M Return
+2.36%
1Y Return
+27.42%
Forward P/E
24.7x
Unified AI Score
42.6 / 100
HOLD
Tech 25.0
Fund 37.0
Flow 50.0
Mom 40.0
AORT
NYSE
Artivion, Inc.
Surgical & Medical Instruments & Apparatus
$18.47
-3.3% 1D
Market Cap
$931.9M
1M Return
-15.2%
1Y Return
-59.49%
Forward P/E
35.5x
Unified AI Score
45.4 / 100
HOLD
Tech 33.0
Fund 51.0
Flow 64.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
UFPT +27.42%
AORT -59.49%
Spread: +86.91 pp (UFPT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
UFPT TTM Op. Margin: 15.4%
AORT TTM Op. Margin: 7.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UFPT vs AORT. Trailing 12-month operating profitability (UFPT 15.4% vs AORT 7.6%) and valuation multiples (UFPT 24.7x vs AORT 35.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UFPT | AORT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.4B | $931.9M | Larger Scale | UFPT |
| Trailing P/E Ratio Valuation | 31.2x | 30.2x | Lower Multiple | AORT |
| Forward P/E Ratio Valuation | 24.7x | 35.5x | Lower Multiple | UFPT |
| Revenue Growth (YoY) Growth | +11.6% | +9.2% | Higher Growth | UFPT |
| Operating Margin (TTM) Profitability | 15.4% | 7.6% | Higher Margin | UFPT |
| Net Profit Margin Profitability | 11.8% | -3.6% | Higher Margin | UFPT |
| Return on Equity (ROE) Capital Efficiency | 17.2% | -4.0% | Higher ROE | UFPT |
| 52-Week Range Position Momentum | 74% ($174โ$342) | 1% ($18โ$48) | Stronger Trend | UFPT |
| Beta / 30D Volatility Risk Regime | 1.64ฮฒ ยท 77% Vol | 0.45ฮฒ ยท 92% Vol | Lower Realized Risk | UFPT |
| Unified Institutional Score Composite Signal | 42.6 / 100 (HOLD) | 45.4 / 100 (HOLD) | Higher Composite | AORT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full UFPT vs AORT Buy Guide
UFPT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
AORT
BREAKDOWN
65d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
20th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither UFPT nor AORT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.